Your Messages Inbox
Your Article Summary
See Latest ArticlesMerck Announces Third-Quarter 2009 Financial Results
Merck & Co., 10/23/09
Merck & Co., Inc. announced financial results for the third quarter of 2009. The company reported non–GAAP earnings per share for the quarter of $0.90, which excludes a $1.7 billion after–tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre–closing merger–related expenses. Third–quarter GAAP EPS was $1.61.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09
Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09
Article Search
Sponsor